CARE vs SPFI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

CARE

49.0
AI Score
VS
CARE Wins

SPFI

43.4
AI Score

Investment Advisor Scores

CARE

49score
Recommendation
HOLD

SPFI

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE SPFI Winner
Forward P/E 13.6612 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.1% 20.0% SPFI
Earnings Growth 45.8% 10.4% CARE
Tradestie Score 49.0/100 43.4/100 CARE
Profit Margin 45.7% 29.6% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CARE 1M: -3.2% · 3M: -10.6% SPFI 1M: +0.7% · 3M: -5.7%

Current Technical Phase

CARE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.9%), weak momentum, RSI 44

RSI (14): 43.9 · Price: $29.22

SPFI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -0.9%) with fading momentum, RSI 47

RSI (14): 47.1 · Price: $43.04

Fundamentals Snapshot

Metric CARE SPFI
Market Cap — —
Forward P/E 11.7 10.4
Trailing P/E 5.0 11.4
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 1.0% 1.0%
Operating Margin 0.2% 0.4%
EPS 5.91 3.78
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.